X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-07-21 | OKYO | Brancaccio John P | Dir | P - Purchase | $1.48 | +5,000 | 35,201 | +17% | +$7,385 | |||||
| A | 2026-07-22 | OKYO | Dempsey Robert John | CEO | P - Purchase | $1.54 | +15,000 | 15,000 | New | +$23,085 | |||||
| A | 2026-07-21 | OKYO | Jacob Gary S | CHIEF DEVELOPMENT OFFICER | P - Purchase | $1.40 | +3,500 | 112,420 | +3% | +$4,900 | |||||
| A | 2026-07-21 | OKYO | Cerrone Gabriele M | Dir, 10% | P - Purchase | $1.45 | +22,500 | 10,873,916 | 0% | +$32,625 | |||||
| A | 2026-07-20 | OKYO | Cerrone Gabriele M | Dir, 10% | P - Purchase | $1.40 | +25,000 | 10,851,416 | 0% | +$35,000 | |||||
| A | 2026-07-21 | OKYO | Mantelli Flavio | CHIEF MEDICAL OFFICER | P - Purchase | $1.40 | +20,000 | 20,000 | New | +$28,000 | |||||
| A | 2026-07-27 | OKYO | Patil Rajkumar V. | Chief Scientific Officer | P - Purchase | $1.49 | +3,363 | 20,030 | +20% | +$5,011 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |